NET Patient Foundation Research Abstracts
NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in England using English cancer registry data, with an aim to also access Scottish, Welsh and Northern Irish cancer registry data to also get UK wide statistics.
We carried out four pieces of research in 2017, abstracts for which can be found below:
- The Incidence and Prevalence of Neuroendocrine Tumours in England.
- The 1- year survival rates for Neuroendocrine tumour patients in England.
- Metachronus primary cancers in Neuroendocrine tumour patients.
- Neuroendocrine Tumour patients experiences of support in the community setting across the treatment trajectory.
Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic Neuroendocrine tumours
Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme
Self-reported side effects in neuroendocrine tumour (NET) patients prescribed somatostatin analogues – the role for specialist dietitians and nurses
- Assess what symptoms/side effects patients report on SSA’s.
- Assess the severity of symptoms/side effects reported by patients whilst on SSA’s.
- Produce recommendations on how to deal with symptoms commonly experienced by patients on SSA’s.
This study has been accepted to be published in the British Journal of Nursing.
Recent News
New podcast: Exploring Neuroendocrine Cancer Epidemiology with Prof. John Ramage
Exciting News: New Podcast Episode is Live! - We're thrilled to announce the release of our latest 'Not Just NE Cancer Takeover' podcast episode, now available for your listening pleasure. In this episode, we have a fascinating conversation with Professor John Ramage,...
*New Patient Story* ‘From Diagnosis to Youtube’ by Alan
- Please read Alan's incredible story. A devoted father, husband, and pet enthusiast, Alan's story is one of resilience, determination, and hope. Discover how he faced the challenges of an uncertain diagnosis, underwent surgery, and found solace in counselling. Alan's...
In Memoriam: Remembering Jimmy Buffett and Raising Awareness of Merkel Cell Carcinoma
- On the 1st of September, Jimmy Buffett passed away after a valiant four-year battle with NEN Merkel cell skin cancer. His legacy as an artist and his journey with this rare form of cancer serve as a poignant reminder of the importance of awareness, support, and...